Abstract: |
Current approaches to cancer immunotherapy aim to engage the natural T cell response against tumors. One limitation is the elimination of self-antigen-specific T cells from the immune repertoire. Using a system in which precursor frequency can be manipulated in a murine melanoma model, we demonstrated that the clonal abundance of CD4+ T cells specific for self-tumor antigen positively correlated with antitumor efficacy. At elevated precursor frequencies, intraclonal competition impaired initial activation and overall expansion of the tumor-specific CD4+ T cell population. However, through clonally derived help, this population acquired a polyfunctional effector phenotype and antitumor immunity was enhanced. Conversely, development of effector function was attenuated at low precursor frequencies due to irreversible T cell exhaustion. Our findings assert that the differential effects of T cell clonal abundance on phenotypic outcome should be considered during the design of adoptive T cell therapies, including use of engineered T cells. Self-reactive tumor-specific CD4+ T cells are eliminated from the immune repertoire during negative selection. Wolchok and colleagues demonstrate that the clonal abundance of melanocyte-specific CD4+ T cells instructs the development effector function and shapes the potential for T cell exhaustion with profound effects on anti-tumor efficacy. © 2016 Elsevier Inc. |